Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (20 ops.)
Latest filing published 08 Mar 2023 for Teva Pharmaceutical Industries Ltd, €512k.
Filing timeline
BuySaleSven Dethlefs
Insider track record
Disclosed buys
1
Disclosed sells
20
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -67.7%Entry US$22.57 · Close at T+365 US$7.29
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sven Dethlefs: trading record in brief
Sven Dethlefs, EVP Global Marketing&Portfolio at Teva Pharmaceutical Industries Ltd, has 48 filings published between March 6, 2018 and March 8, 2023. Option exercises make up the majority, with 25 filings, ahead of 20 sales and 2 share grants. A single purchase is in the record: EUR 37,839, on August 3, 2018, or 5% of the open-market trades.
The sales are numerous and limited in size, with a median of EUR 41,395 and EUR 1,949,589 in total. The three largest are dated March 7, 2023 (EUR 512,299), February 28, 2023 (EUR 394,334) and February 9, 2021 (EUR 252,271). The year 2021 is the busiest, with 10 filings, ahead of 2018 (9) and 2019 (7).
Filings appear a median of 2 days after the trade, and none falls in the last twelve months, the latest being from March 2023.
The count of trades by Dethlefs within 30 days of colleagues at Teva Pharmaceutical Industries Ltd is 20, 19 and 15, all of them in the same direction. Colleagues in order: Richard Daniell, David Matthew Stark and Hafrun Fridriksdottir.
Companies and markets linked to Sven Dethlefs
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations48 total
58,066 shares@ US$9.4325.6% of flowOrdinary SharesSEC:0001209191-23-017155:1
19,355 shares@ US$9.9309100.0% of flowOrdinary SharesSEC:0001209191-23-017155:0
38,538 sharesOrdinary SharesSEC:0001209191-23-016688:1
24,952 sharesOrdinary SharesSEC:0001209191-23-016688:2
13,931 sharesOrdinary SharesSEC:0001209191-23-016688:0
17,346 shares@ US$9.898.1% of flowOrdinary SharesSEC:0001209191-23-014436:1
42,309 shares@ US$9.8919.7% of flowOrdinary SharesSEC:0001209191-23-014436:3
42,309 sharesOrdinary SharesSEC:0001209191-23-014436:2
17,346 sharesOrdinary SharesSEC:0001209191-23-014436:0
3,904 shares@ US$7.481.3% of flowOrdinary SharesSEC:0001209191-22-017035:2
6,993 shares@ US$7.372.4% of flowOrdinary SharesSEC:0001209191-22-017035:4
13,930 sharesOrdinary SharesSEC:0001209191-22-017035:1
24,952 sharesOrdinary SharesSEC:0001209191-22-017035:3
37,939 sharesOrdinary SharesSEC:0001209191-22-017035:0
4,862 shares@ US$8.141.8% of flowOrdinary SharesSEC:0001209191-22-014467:1
17,346 sharesOrdinary SharesSEC:0001209191-22-014467:0
4,138 shares@ US$9.061.6% of flowOrdinary SharesSEC:0001209191-22-008412:1
13,135 sharesOrdinary SharesSEC:0001209191-22-008412:0
6,012 shares@ US$10.576.7% of flowOrdinary SharesSEC:0001209191-21-018510:1
13,930 sharesOrdinary SharesSEC:0001209191-21-018510:0
1,400 sharesOrdinary SharesSEC:0001209191-21-017756:0
606 shares@ US$10.860.7% of flowOrdinary SharesSEC:0001209191-21-017756:1
17,346 sharesOrdinary SharesSEC:0001209191-21-015826:0
7,486 shares@ US$10.838.5% of flowOrdinary SharesSEC:0001209191-21-015826:1
5,695 shares@ US$12.697.6% of flowOrdinary SharesSEC:0001209191-21-009628:2
25 of 48 declarations
